CVI Holdings LLC Takes $520,000 Position in Allurion Technologies Inc. (NYSE:ALUR)

CVI Holdings LLC bought a new position in Allurion Technologies Inc. (NYSE:ALUR) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 521,440 shares of the company’s stock, valued at approximately $520,000. Allurion Technologies makes up 0.5% of CVI Holdings LLC’s portfolio, making the stock its 28th biggest holding.

Separately, Accredited Investors Inc. grew its position in Allurion Technologies by 33.3% during the 2nd quarter. Accredited Investors Inc. now owns 50,000 shares of the company’s stock worth $50,000 after acquiring an additional 12,500 shares during the last quarter. 21.39% of the stock is owned by hedge funds and other institutional investors.

Allurion Technologies Stock Performance

Shares of ALUR opened at $0.63 on Friday. The firm has a market capitalization of $30.00 million, a price-to-earnings ratio of -0.17 and a beta of -0.33. The business’s fifty day moving average price is $0.70 and its two-hundred day moving average price is $1.39. Allurion Technologies Inc. has a 52 week low of $0.55 and a 52 week high of $5.15.

Allurion Technologies (NYSE:ALUR) last announced its quarterly earnings data on Tuesday, August 13th. The company reported $0.01 EPS for the quarter. The firm had revenue of $11.77 million during the quarter. As a group, research analysts forecast that Allurion Technologies Inc. will post -0.3 EPS for the current year.

Wall Street Analysts Forecast Growth

ALUR has been the topic of a number of research analyst reports. Roth Mkm initiated coverage on Allurion Technologies in a research report on Friday, September 6th. They set a “buy” rating and a $2.00 price target on the stock. Chardan Capital decreased their price target on Allurion Technologies from $5.00 to $2.50 and set a “buy” rating on the stock in a research report on Thursday, August 22nd. Finally, Roth Capital upgraded Allurion Technologies to a “strong-buy” rating in a research report on Friday, September 6th.

Allurion Technologies Company Profile

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.